http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107200724-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-20 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-20 |
| filingDate | 2016-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107200724-B |
| titleOfInvention | Duloxetine hydrochloride single crystal and preparation method thereof |
| abstract | The invention relates to a preparation method of duloxetine hydrochloride single crystal A, which comprises a liquid-liquid interface diffusion method or a vapor-liquid interface diffusion method. The preparation method of the invention has the advantages of rapid preparation, few defects of the obtained single crystal, simple operation, low cost, safety and reliability. |
| priorityDate | 2016-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.